Previous 10 | Next 10 |
home / stock / azncf / azncf news
2023-05-16 16:46:23 ET Summary We continue our analytics coverage of AstraZeneca PLC with a "hold" rating for the next 12 months. AstraZeneca's revenue for the first three months of 2023 was $10.88 billion, down 2.9% from the previous quarter and 4.5% from the first quarter of 202...
2023-05-14 03:56:00 ET Summary Industry-leading pharmaceutical firms are adopting artificial intelligence to drive value for the future of their enterprise. Several companies in the VanEck Pharmaceutical ETF are currently integrating AI into their operations. The global pharma...
2023-05-04 04:30:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron International Growth Fund gained 3.75% (Institutional Shares) during the first q...
2023-05-01 06:39:12 ET The following slide deck was published by AstraZeneca PLC in conjunction with this event. For further details see: AstraZeneca (AZN) Presents at the 2023 American Association for Cancer Research (AACR) - Slideshow
2023-04-27 14:12:14 ET AstraZeneca PLC (AZN) Q1 2023 Earnings Conference Call April 26, 2023, 06:45 AM ET Company Participants Andy Barnett - VP Global Head of IR Pascal Soriot - CEO Aradhana Sarin - CFO Dave Fredrickson - EVP of Oncology Business Unit Su...
2023-04-21 06:00:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. An emphasis on quality...
2023-04-17 13:43:35 ET Summary In this article, we will present a comparative analysis of these two companies, one of which is becoming more and more attractive to long-term investors. However, excluding COVID-19 products from the calculations, AstraZeneca's revenue was $10,388 mi...
2023-04-14 11:28:52 ET Summary Pharmaceuticals/biotechnology is the only subsector with good value and quality scores. Healthcare equipment is the most overvalued one. IXJ: A global alternative to XLV. 10 stocks cheaper than their peers in April. This monthly art...
2023-04-10 08:26:10 ET Summary GSK's dividend yield is 3.58%, slightly higher than Bristol-Myers Squibb's 3.22%. Bristol-Myers Squibb's total debt was about $40.8 billion at the end of 2022, down $4.78 billion from the previous year, thanks to the successful integration of Celgene...
2023-03-23 22:05:05 ET Summary BOE shares some similarities with BDJ but has a sizeable portion of its portfolio outside the U.S. The fund's performance in 2022 was helped out by call writing, but having some heavier weightings in tech seemed to hurt results. BOE is currently ...
News, Short Squeeze, Breakout and More Instantly...
Inaugural Asia Summit on Global Health successfully explores healthcare landscape HONG KONG, Nov 25, 2021 - (ACN Newswire) - Co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC), the inaugural...
Inaugural Asia Summit on Global Health opens today HONG KONG, Nov 24, 2021 - (ACN Newswire) - Co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC), the inaugural Asia Summit on Global Health (...
A new study with information regarding the “rare but devastating” blood clotting issue affiliated with the Oxford- AstraZeneca (OTCMKTS: AZNCF) Covid-19 vaccine has been released. Nevertheless, according to British scientists, there have been no new cases of blood cl...